New funding encourages Australian researchers to work with industry
Five new NHMRC Industry Fellowships worth $1.6 million announced today will encourage researchers to learn more about the commercial aspects of R&D, according to the Minister for Health and Ageing, Senator Kay Patterson.
5 November 2002
New funding encourages Australian researchers to work with industryFive new NHMRC Industry Fellowships worth $1.6 million announced today will encourage researchers to learn more about the commercial aspects of R&D, according to the Minister for Health and Ageing, Senator Kay Patterson.
NHMRC Industry Fellowships target researchers who wish to spend two years working in industry and two years in a research institution, and aim to foster closer interactions between Australian researchers and industry.
"These Fellowships provide successful applicants with an opportunity to expand their research horizons and gain experience in important facets of the commercial development of research findings, including project planning, business planning, and knowledge of business and industry dynamics," Senator Patterson said.
"They will establish, facilitate and maintain interactions between academia and industry, in particular fostering an understanding of the commercial aspects of R&D within academic institutions," she added.
The successful Fellows will work with industry partners in Australia, Sweden, Switzerland and the USA on research, which includes therapy for ulcers, regulating inflammatory bowel disease, and targeting obesity by manipulating metabolism.
Funding for health and medical research, through the NHMRC, in Australia was doubled by the Commonwealth in the 1999-2000 Federal Budget, as a result of the Wills Review.
Details of the five Industry Fellowships are attached.
NHMRC Industry Fellowships
|Dr Cuong Duy Tran||Women's and Children's Hospital, Adelaide||Numico Research Australia Pty Ltd, Oakden SA||The use of milk derived and derived bioactives in combination with zinc as therapy in the eradication of Helicobacter Pylori infection and associated gastritis.|
|Dr Yum Lina Yip||Victor Chang Cardiac Research Institute Sydney||GlaxoSmithKline R&D, Geneva, Switzerland||Mapping of coding SNPs to protein structure|
|Dr William Geoffrey Dandie||Child Health Research Institute, Adelaide||TGR BioSciences Pty Ltd, Thebarton SA||Identification of bioactive molecules associated with the regulation or control of inflammatory bowel disease.|
|Dr Michael Stanley Rolph|| G2 Therapies Ltd, Darlinghurst NSW
Biogen Inc, Cambridge MA, USA
|Discovery and validation of therapeutic targets for inflammatory disease using genomic technologies.||Garvan Institute for Medical Research, Sydney|
|Dr Amanda Edgley||Monash University, Melbourne||AstraZeneca R&D. Molndal, Sweden||Targeting obesity: manipulating metabolism using genetically modified mice|
Media Contact: Randal Markey, Media Adviser, (02) 6277 7220
Jeanne Klener, NHMRC Communications Unit, (02) 6289 5796